Bekker Zanelle, Walubo Andrew, Du Plessis Jan B
Department of Pharmacology, University of the Free State, P.O. Box 339, Bloemfontein 9300, South Africa.
Adv Pharmacol Sci. 2016;2016:3094783. doi: 10.1155/2016/3094783. Epub 2016 Nov 20.
The aim of this study was to illustrate the initial subclinical drug-induced liver injury and the associated adaptive immune response by monitoring for the changes in plasma IL-2, IL-10, and some cytochrome P450 activity during chronic administration of nevirapine (NVP), isoniazid (INH), and paracetamol (PAR) in rats without clinical hepatotoxicity. Male Sprague-Dawley (SD) rats were divided into four groups (saline (S), NVP, INH, and PAR) of 25 animals each. The drugs were administered daily for 42 days at therapeutic doses (NVP 200 mg/kg, PAR 500 mg/kg, and INH 20 mg/kg) to the respective groups by oral gavage and five rats per group were sacrificed weekly. All the three drugs induced a subclinical liver injury in the first 2-3 weeks followed by healing, indicating adaption. The liver injury was pathologically similar and was associated with immune stimulation and increased cytochrome P450 activity. NVP- and PAR-induced liver injury lasted up to 14 days while that for INH lasted for 28 days. NVP-induced liver injury was associated with increased IL-2, CD4 count, and CYP3A2 activity, followed by increased IL-10 during the healing phase. In conclusion, the initial drug-induced subclinical liver injury, its spontaneous healing, and the associated adaptive immune response have been demonstrated.
本研究的目的是通过监测大鼠长期服用奈韦拉平(NVP)、异烟肼(INH)和对乙酰氨基酚(PAR)期间血浆白细胞介素-2(IL-2)、白细胞介素-10(IL-10)的变化以及一些细胞色素P450活性,来阐明初始亚临床药物性肝损伤及相关的适应性免疫反应,这些大鼠无临床肝毒性。雄性斯普拉格-道利(SD)大鼠被分为四组(每组25只),分别为生理盐水组(S)、NVP组、INH组和PAR组。通过灌胃法,以治疗剂量(NVP 200mg/kg、PAR 500mg/kg、INH 20mg/kg)每日给各相应组大鼠给药42天,每组每周处死5只大鼠。所有这三种药物在最初2 - 3周均诱导了亚临床肝损伤,随后损伤愈合,表明出现了适应性变化。肝损伤在病理上相似,且与免疫刺激和细胞色素P450活性增加有关。NVP和PAR诱导的肝损伤持续长达14天,而INH诱导的肝损伤持续28天。NVP诱导的肝损伤与IL-2、CD4计数及CYP3A2活性增加有关,随后在愈合阶段IL-10增加。总之,已证实了初始药物性亚临床肝损伤、其自发愈合及相关的适应性免疫反应。